Immunotherapy for urothelial carcinoma: current status and perspectives. - Wikidata - wikimedia - TriplyDB

Immunotherapy for urothelial carcinoma: current status and perspectives.

Immunotherapy for urothelial carcinoma: current status and perspectives.

http://www.wikidata.org/entity/Q37137381

about

Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy Role of systemic chemotherapy in urothelial urinary bladder cancer Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.Gene Variants in Predicting BCG Response to Urinary Bladder Cancer.Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.BCG response prediction with cytokine gene variants and bladder cancer: where we are?Immunotherapy: a new treatment paradigm in bladder cancer.Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort.Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model.

P2860

Q26798372-82C4AD1D-881A-43DE-A0FC-9083A550A8B6 Q27010323-F0538257-67E8-4E3B-8D68-D9509F5B5861 Q33563230-66A30946-F979-4904-A598-0176D2419CD4 Q35777730-361F7E99-062D-4622-BFAD-850628418951 Q37457728-E32AEF1D-AF17-4F36-B795-5FE1F450E585 Q37935658-4C228911-1DFB-4069-877E-825EC0A67F1F Q38743589-E9A6A62C-E6FC-4B8F-AC78-25EDCC79675B Q47105909-DA37EC90-CDE7-4FD3-BD9E-FC0988C32C44 Q50928785-16ED8E57-2BAE-4DD9-BF9D-886E1213CE4A

P2860

Immunotherapy for urothelial carcinoma: current status and perspectives.

http://www.wikidata.org/entity/Q37137381

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunotherapy for urothelial carcinoma: current status and perspectives.

@en

Immunotherapy for urothelial carcinoma: current status and perspectives.

@nl

type

label

Immunotherapy for urothelial carcinoma: current status and perspectives.

@en

Immunotherapy for urothelial carcinoma: current status and perspectives.

@nl

prefLabel

Immunotherapy for urothelial carcinoma: current status and perspectives.

@en

Immunotherapy for urothelial carcinoma: current status and perspectives.

@nl

P1433

Q37137381-536C69E5-145D-48B4-92B3-9443FDBB5672

P1476

Q37137381-53B791B3-312B-4213-8CE5-E64D17CFEE8A

P2093

Q37137381-24270DBC-BE4F-4753-BFE5-B023A32313D2

Q37137381-283232F2-0CC6-4F17-974A-5543F58423C8

P2860

Q37137381-009861AA-C671-48B8-BC35-3CD35344CF52

Q37137381-03CF0176-C977-4D4A-A1B6-9C51F6D4FC1C

Q37137381-05059D8D-DE3D-4F35-AD14-9DE5DF1B11A8

Q37137381-0A3A2CCD-2666-4940-B5E1-84BF129A6226

Q37137381-0C9770F4-3C97-4E11-9D41-5B89E60450CC

Q37137381-0DBB1433-F03F-4247-B85E-AEFACF46117B

Q37137381-121221AA-E470-4A7C-8742-861918405404

Q37137381-13F7B9AC-9194-4A72-A3D3-3E0F9C9C8A66

Q37137381-19E5557A-937A-4954-B522-BF971A8803E1

Q37137381-1B02A8CA-F543-4BF4-A46E-8C30DB4EE698

P304

Q37137381-EFB32CF8-C980-45FE-A4FC-77B5D4943372

P31

Q37137381-176D724A-ADF7-4431-94E4-3D09F4751B1A

P356

Q37137381-1FDEFC3C-8795-43CE-A555-D2297B38ADF4

P433

Q37137381-44E27517-CA22-439B-BAAA-054709B61592

P478

Q37137381-6AD59312-6881-4DEB-BFA2-221F5FC7A787

P577

Q37137381-B58C0124-539B-4161-91CB-B71C79F050F3

P5875

Q37137381-C567EFAE-5A9E-4E4B-9F4E-8EA3273CF1C6

P698

Q37137381-7F107CA8-11CB-43B4-AEBC-8F84E6896344

P921

Q37137381-859ACCE5-5ED0-4612-A8DD-454D702F5D26

P932

Q37137381-54D4C069-216D-4BD6-AC3E-533657651220

P356

P1433

P1476

Immunotherapy for urothelial carcinoma: current status and perspectives.

@en

P2093

Hiroshi Kitamura

http://www.w3.org/2001/XMLSchema#string

Taiji Tsukamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).

Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy.

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

Feasibility of T-cell-based adoptive immunotherapy in the first 12 patients with advanced urothelial urinary bladder cancer. Preliminary data on a new immunologic treatment based on the sentinel node concept.

Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines.

P304

3055-3072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS3033055

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258429756

http://www.w3.org/2001/XMLSchema#string

P698

24212945

http://www.w3.org/2001/XMLSchema#string

P921

P932

3759186

http://www.w3.org/2001/XMLSchema#string